At Reprogram Biosciences, cell reprogramming is at the center of a new way of thinking about therapeutics. Below, Rustam Esanov (CEO) and Eziz Kuliyev (COO) from Reprogram Bio shares—in their own words—how the team is approaching this shift, where they are focusing first, and how partnering with Helix has helped accelerate their work.​ Reprogram’s Mission and Current Focus “To start, could you give a quick overview of Reprogram Biosciences and what your current main project

When Should You Use a Standard LNP Composition versus a Custom Lipid/Polymer Formulation?

Moving a lipid- or polymer-based nanoparticle formulation from lab scale to GMP manufacturing is a complex process. Tech transfer is a critical stage where many projects face delays, increased costs, or regulatory hurdles due to missing or unclear steps. Careful preparation before engaging a Contract Development and Manufacturing Organization (CDMO) is essential to avoid these pitfalls. By approaching the transfer methodically, you can significantly reduce risk and ensure you